An Adaptative Randomized Phase II Study on the Timing of FOLFOX for Patients With Operable Stage III Rectal Cancer.
Phase of Trial: Phase II
Latest Information Update: 05 Dec 2016
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary)
- Indications Rectal cancer
- Focus Therapeutic Use
- 19 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2017, as reported by ClinicalTrials.gov.
- 09 Oct 2012 Planned number of patients changed from 240 to 180.
- 21 Jan 2011 New trial record